|
Sign In to gain access to subscriptions and/or personal tools.
|
Rett Syndrome: A Prototypical Neurodevelopmental Disorder
Jeffrey L. Neul
Department of Pediatrics, Baylor College of Medicine, Houston
Huda Y. Zoghbi
Departments of Pediatrics, Molecular and Human Genetics, Neurology, and Neuroscience and the Howard Hughes Medical Institute, Baylor College of Medicine, Houston, hzoghbi{at}bcm.tmc.edu
Rett syndrome, one of the leading causes of mental retardation and developmental regression in girls, is the first pervasive developmental disorder with a known genetic cause. The majority of cases of sporadic Rett syndrome are caused by mutations in the gene encoding methyl-CpG-binding protein 2 (MeCP2). MeCP2 binds methylated DNA and likely regulates gene expression and chromatin structure. Genotype/phenotype analysis revealed that the phenotypic spectrum of MECP2 mutations in humans is broader than initially suspected: Mutations have been discovered in Rett syndrome variants, mentally retarded males, and autistic children. A variety of in vivo and in vitro models has been developed that allow analysis of MeCP2 function and pathogenic studies of Rett syndrome. Because the neuropathology of Rett syndrome shares certain features with other neurodevelopmental disorders, a common pathogenic process may underlie these disorders. Thus, Rett syndrome is a prototype for the genetic, molecular, and neurobiological analysis of neurodevelopmental disorders.
Key Words: MeCP2 MBD Synapse Autism Angelman
The Neuroscientist, Vol. 10, No. 2,
118-128 (2004)
DOI: 10.1177/1073858403260995

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Mironov
Respiratory Circuits: Function, Mechanisms, Topology, and Pathology
Neuroscientist,
April 1, 2009;
15(2):
194 - 208.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Samaco, J. D. Fryer, J. Ren, S. Fyffe, H.-T. Chao, Y. Sun, J. J. Greer, H. Y. Zoghbi, and J. L. Neul
A partial loss of function allele of Methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome
Hum. Mol. Genet.,
June 15, 2008;
17(12):
1718 - 1727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Neul, P. Fang, J. Barrish, J. Lane, E. B. Caeg, E. O. Smith, H. Zoghbi, A. Percy, and D. G. Glaze
Specific mutations in Methyl-CpG-Binding Protein 2 confer different severity in Rett syndrome
Neurology,
April 15, 2008;
70(16):
1313 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Guy, J. Gan, J. Selfridge, S. Cobb, and A. Bird
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Science,
February 23, 2007;
315(5815):
1143 - 1147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. K. Glasmacher, V. R. Sutton, B. Hopkins, T. Eble, R. A. Lewis, D. Park Parsons, and I. B. Van den Veyver
Phenotype and Management of Aicardi Syndrome: New Findings from a Survey of 69 Children
J Child Neurol,
February 1, 2007;
22(2):
176 - 184.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Changeux
The Ferrier Lecture 1998 The molecular biology of consciousness investigated with genetically modified mice
Phil Trans R Soc B,
December 29, 2006;
361(1476):
2239 - 2259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. I. Young, E. P. Hong, J. C. Castle, J. Crespo-Barreto, A. B. Bowman, M. F. Rose, D. Kang, R. Richman, J. M. Johnson, S. Berget, et al.
Inaugural Article: Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2
PNAS,
December 6, 2005;
102(49):
17551 - 17558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Amir, V. R. Sutton, and I. B. Van den Veyver
Newborn Screening and Prenatal Diagnosis for Rett Syndrome: Implications for Therapy
J Child Neurol,
September 1, 2005;
20(9):
779 - 783.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Amir, V. Reid Sutton, and I. B. Van den Veyver
Newborn Screening and Prenatal Diagnosis for Rett Syndrome: Implications for Therapy
J Child Neurol,
August 1, 2005;
20(8):
779 - 783.
[Abstract]
[PDF]
|
 |
|
|
|